{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:47:28Z","timestamp":1774900048034,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.neurol.2015.11.007","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T20:33:41Z","timestamp":1460234021000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Drugs with potential cardiac adverse effects: Retrospective study in a large cohort of parkinsonian patients"],"prefix":"10.1016","volume":"172","author":[{"given":"A.","family":"Heranval","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lefaucheur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rouill\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Malt\u00eate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.neurol.2015.11.007_bib0170","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmocological treatment of Parkinson's disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.neurol.2015.11.007_bib0175","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00002826-198612000-00003","article-title":"Domperidone and Parkinson's disease","volume":"9","author":"Parkes","year":"1986","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"10.1016\/j.neurol.2015.11.007_bib0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2125.2008.03334.x","article-title":"Influence of domperidone on pharmacokinetics, safety, and tolerability of the dopamine agonist rotigotine","volume":"67","author":"Braun","year":"2009","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.neurol.2015.11.007_bib0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10286-007-0410-7","article-title":"Autonomic and cognitive dysfunction in Parkinson's disease","volume":"17","author":"Idiaquez","year":"2007","journal-title":"Clin Auton Res"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2015.11.007_bib0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2009.08.031","article-title":"Cardiovascular autonomic dysfunction in Parkinson's disease","volume":"289","author":"Ziemssen","year":"2010","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.neurol.2015.11.007_bib0195","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/cphy.c130026","article-title":"Dysautonomia in Parkinson disease","volume":"4","author":"Goldstein","year":"2014","journal-title":"Compr Physiol"},{"issue":"1","key":"10.1016\/j.neurol.2015.11.007_bib0200","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neurol.2015.11.007_bib0205","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/mds.21428","article-title":"Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease","volume":"22","author":"Schoffer","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2015.11.007_bib0210","doi-asserted-by":"crossref","DOI":"10.1002\/nau.22764","article-title":"A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders","author":"Sakakibara","year":"2015","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"10.1016\/j.neurol.2015.11.007_bib0215","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199903113401003","article-title":"Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease","volume":"340","author":"The Parkinson Study Group","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2015.11.007_bib0220","first-page":"CD006504","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies. Parkinson's disease dementia and cognitive impairment in Parkinson's disease","volume":"3","author":"Rolinski","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.neurol.2015.11.007_bib0225","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mds.25870","article-title":"Cognitive impairment and dementia in Parkinson's disease: practical issues and management","volume":"29","author":"Emre","year":"2014","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurol.2015.11.007_bib0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson's disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.neurol.2015.11.007_bib0235","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0269881113478282","article-title":"Antidepressants for depression in Parkinson's disease: systematic review and meta-analysis","volume":"27","author":"Rocha","year":"2013","journal-title":"J Psychopharmacol"},{"issue":"11","key":"10.1016\/j.neurol.2015.11.007_bib0240","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2165\/11536840-000000000-00000","article-title":"Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands","volume":"33","author":"Van Noord","year":"2010","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.neurol.2015.11.007_bib0245","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40264-014-0161-z","article-title":"Cardiovascular effects of drugs used to treat Alzheimer's disease","volume":"37","author":"Howes","year":"2014","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.neurol.2015.11.007_bib0250","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.parkreldis.2013.02.004","article-title":"Prescription of drugs with potential adverse effects on cardiac conduction in Parkinson's disease","volume":"19","author":"Malek","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.neurol.2015.11.007_bib0255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neursurosurg Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.neurol.2015.11.007_bib0260","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.3949\/ccjm.76.s2.10","article-title":"Cardiac sympathetic denervation preceding motor signs in Parkinson disease","volume":"76","author":"Goldstein","year":"2009","journal-title":"Cleve Clin J Med"},{"issue":"11","key":"10.1016\/j.neurol.2015.11.007_bib0265","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(03)00555-6","article-title":"Dysautonomia in Parkinson's disease: neurocardiological abnormalities","volume":"2","author":"Goldstein","year":"2003","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2015.11.007_bib0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10286-009-0002-9","article-title":"Cardiac sympathetic neuroimaging: summary of the First International Symposium","volume":"19","author":"Goldstein","year":"2009","journal-title":"Clin Auton Res"},{"issue":"3","key":"10.1016\/j.neurol.2015.11.007_bib0275","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000117432","article-title":"Prolongation of QTc intervals in patients with Parkinson's disease","volume":"37","author":"Oka","year":"1997","journal-title":"Eur Neurol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2015.11.007_bib0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-510X(02)00079-5","article-title":"Abnormalities of rate-corrected QT intervals in Parkinson's disease\u00a0\u2013\u00a0a comparison with multiple system atrophy and progressive supranuclear palsy","volume":"199","author":"Deguchi","year":"2002","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.neurol.2015.11.007_bib0285","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ahj.2014.11.018","article-title":"Parkinson disease and risk of acute myocardial infarction: a population-based, propensity score-matched, longitudinal follow-up study","volume":"169","author":"Liang","year":"2015","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.neurol.2015.11.007_bib0290","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.2337\/dc11-1584","article-title":"Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis","volume":"34","author":"Cereda","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.neurol.2015.11.007_bib0295","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/HYPERTENSIONAHA.111.171249","article-title":"Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study","volume":"57","author":"Qiu","year":"2011","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.neurol.2015.11.007_bib0300","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/pds.2016","article-title":"Risk of serious ventricular arrhytmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study","volume":"19","author":"Johannes","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"24","key":"10.1016\/j.neurol.2015.11.007_bib0305","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.neurol.2015.11.007_bib0310","doi-asserted-by":"crossref","first-page":"e1000157","DOI":"10.1371\/journal.pmed.1000157","article-title":"Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study","volume":"6","author":"Park-Wyllie","year":"2009","journal-title":"PLoS Med"},{"issue":"9193","key":"10.1016\/j.neurol.2015.11.007_bib0315","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neurol.2015.11.007_bib0320","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N Eng J Med"},{"issue":"7","key":"10.1016\/j.neurol.2015.11.007_bib0325","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mds.20051","article-title":"Long-term outcome of clozapine use for psychosis in parkinsonian patients","volume":"19","author":"Fernandez","year":"2004","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.neurol.2015.11.007_bib0330","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.amjmed.2011.12.002","article-title":"Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?","volume":"125","author":"Vieweg","year":"2012","journal-title":"Am J Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716004318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716004318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T14:20:51Z","timestamp":1536848451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378716004318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":33,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0035378716004318"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2015.11.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs with potential cardiac adverse effects: Retrospective study in a large cohort of parkinsonian patients","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2015.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}